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Bee products are a promising source of phenolic compounds with strong antioxidant activity. The present study was designed to
explore the protective effect of honey, propolis, and their combination on gentamicin-induced oxidative stress and hepatorenal
dysfunction. This study was conducted on male Wistar rats by intraperitoneal injections of gentamicin (120mg/kg BW/day,
i.p.) or normal saline (1ml/kg BW/day, i.p.) for 10 consecutive days. Honey (2 g/kg BW), propolis (100mg/kg BW), or their
combination were given daily by gavage to normal and gentamicin groups. Honey and propolis samples were evaluated for
their phytochemical composition and antioxidant capacity. The in vitro investigations showed that the evaluated samples
especially propolis extract have high antioxidant power associated with the presence of several phenolic compounds such as
flavonoids, flavan-3-ols, hydroxybenzoic acids, hydroxycinnamic acids, and stilbenes, while honey contains only hydroxybenzoic
acids and hydroxycinnamic acids. It was also shown that simultaneous treatment with honey or propolis extract alone or in
association prevented changes caused by gentamicin administration and improved hepatic and renal functions. Changes caused
by gentamicin administration, observed by in vivo experiments, include significant elevation of uric acid, urea, creatinine, and
hepatic enzyme levels (ALT, AST, and ALP) and kidney biochemical changes (an increase of urea, uric acid, and creatinine and
a decrease of albumin and total protein) as well as remarkable changes of renal and liver oxidative stress markers (CAT, GPx,
and GSH) and elevation of MDA levels. Overall, it can be concluded that honey and propolis might be useful in the
management of liver and renal diseases induced by xenobiotics.
1. Introduction
Aminoglycoside antibiotics, especially gentamicin (GENT),
are widely used in the treatment of human and animal bac-
terial infections, particularly aerobic Gram-negative bacteria.
However, the clinical usefulness of gentamicin is limited by
its serious side effects on liver and kidney functions [1].
Chronic treatment with GENT prompts tubular necrosis,
reduced renal blood flow (RBF), and glomerular filtration
rate (GFR) [2]. Previous studies suggest that GENT-
toxicity is a complex process in which GENT triggers cellu-
lar responses involving various pathways that result in liver
and renal injuries [3, 4]. Until the moment, the precise
mechanism of GENT hepatonephrotoxicity is not fully
understood. Several hypotheses were proposed to explain
the involved mechanism of toxicity pathways; oxidative
stress is the most reinforced one. Reactive oxygen species
(ROS) and other free radicals were considered to be one of
the important mediators of GENT-toxicity [5]. In vivo and
in vitro investigations have revealed that GENT stimulates
the overproduction of ROS metabolites, leading to necrosis
and cellular injury through different pathways, including
protein oxidation, lipid peroxidation, and DNA damage. In
addition, the excess of free radicals’ generation enhances
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the activation of nitrosative tissue stress, inflammatory
markers, modulation of the caspase family, and mitogen-
activated protein kinases [6]. It has also been documented
that nuclear factor-kappa B (NF-κB), mitogen-activated pro-
tein kinase (MAPK), and redox-sensitive transcription fac-
tors are associated with GENT-toxicity [7, 8]. Therefore,
many researchers are interested in finding new effective
and safer antioxidant compounds able to prevent xenobiotic
adverse effects.
Since ancient times, honey and propolis were used for
the prevention and self-treatment of various illnesses and
human disorders [9, 10]. Honey is a functional food pro-
duced by bees on mixing plant nectar with its hypopharyn-
geal excretions [11]. Due to its diverse content of pollen
and nectar from different melliferous plants, honey has a
wide complex mixture of components. Generally, it contains
more than 75% of sugars, around 17% of water, and 3.5% of
other minor elements including phenolic compounds,
organic acids, proteins, amino acids, enzymes minerals,
and vitamins [12]. Owing to this multifaceted composition,
honey plays a crucial function in the management of several
pathologies such as cancer, inflammation, diabetes, and gas-
trointestinal dysfunction [13, 14]. Bee glue or propolis is a
sticky organic substance produced by honeybees from differ-
ent exudates and plant buds mixed with wax, pollen, and
saliva. It is applied by honeybees as a hive defensive material
against various infections. Propolis has been used in folk
medicine by different civilizations around the world as a
remedy for various illnesses and health disorders [15]. Now-
adays, it has become the objective of many scientific investi-
gations. Several reports have documented that propolis
extracts possess a broad spectrum of pharmacological
actions such as antidiabetic, antimicrobial, and antitumoral
effects [15, 16]. Moreover, it was discovered that propolis
has a potent protective action in kidney and liver damages
[17] which makes it an ideal preventive candidate against
GENT adverse effects. It is well documented that the antiox-
idant capacities of natural products, including beekeeping
products, are mostly associated with in vivo activities [18].
The assessment of the antioxidant capacity and the quantifi-
cation of bioactive constituents from honey and propolis by
validated and recommended assays are crucial steps to pre-
dict their efficacy on oxidative stress and associated patholo-
gies [19, 20]. It has been reported that binary or multiple
mixtures of food extracts or their individual bioactive com-
ponents provide synergy with regard to antioxidant status,
anti-inflammation, anticancer, and chemoprevention of sev-
eral oxidative stress and metabolic disorders [21]. In this
context, this study is aimed at assessing the antioxidant
potential, identification, and quantification of polyphenols
from honey and propolis as well as evaluating their protec-
tive effects alone or in combination on GENT-induced oxi-
dative stress and hepatoreno toxicity in Wistar rats.
2. Material and Methods
2.1. Honey and Propolis Samples and Extract Preparations.
Organic honey and propolis sample were collected in July
2018, from modern and healthy hives installed in the Sefrou
region (latitude: 33°49′49.89″N; longitude: 4°50′7.14″W;
and altitude: 823m).
According to our previous survey [22], the predominant
vegetation species present around the hives were Prunus cer-
asus L, Prunus domestica L, Ceratonia siliqua L, Rosa canina
L, Olea europaea L, Rosmarinus officinalis L, Ruta graveolens
L, Pinus halepensis Mill, and Quercus ilex L.
For experimental assays, propolis extract was obtained
with ethanol (70%, v/v). For that one gram of raw propolis
was macerated in 30ml of ethanol-water (70-30, v/v) under
mechanical stirring for one week. The final extracts were fil-
tered (Whatman, n°1), and the supernatant was collected.
One part of the resulting liquid extract was used for chemical
analyses and in vitro antioxidant tests. Another part was
subsequently concentrated in a rotary evaporator (Model
R-200, Büchi labortechnik AG, Switzerland), and distilled
water was added to prepare the chosen concentrations for
in vivo tests. For honey, 2 g of material was dissolved in
10ml of distilled water and subsequently diluted to prepare
the desired concentration. Honey and propolis combination
was also studied.
2.2. Chemicals. Sodium tungstate, sodium molybdate, phos-
phoric acid, lithium sulfate, sodium carbonate (Na2CO3), gal-
lic acid, sodium nitrite (NaNO2), aluminum chloride (AlCl3),
sodium hydroxide (NaOH), sodium carbonate (Na2CO3),
2,2-Di(4-tert-octylphenyl)-1-picrylhydrazyl (DPPH), 2,2′
-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammo-
nium salt (ABTS), potassium persulfate, ferric chloride
(FeCl3), and all HPLC standard markers (vanillic acid,
o-coumaric acid, ferulic acid, ellagic acid, naringin, hesperi-
din, apigenin, cinnamic acid, resveratrol, rosmarinic acid,
rutin, chlorogenic acid, gallic acid, quercetin, and kaempferol)
were obtained from Sigma-Aldrich (St. Louis, MO, USA).
2.3. Chemical Analyses of Extracts
2.3.1. Total Polyphenol Content (TPC). Total polyphenols
were determined by the Folin-Ciocalteu method following
the procedure described by Santos et al. [23]. Briefly, 15μl
of Folin-Ciocalteu reagent sodium tungstate (10 g) and
sodium molybdate (2.5 g) was dissolved in 70ml of distilled
water; then, 5ml of phosphoric acid (85%) and 10ml of con-
centrated hydrochloric acid were added. After 10 hours, 15 g
of lithium sulfate and 5ml of distilled water were added, and
100ml with distilled water and 60μl of sodium carbonate
(Na2CO3, 75 g/l) were added to 5μl of honey or propolis
extracts. The intensity of the produced color was read at
700 nm by a UV/Vis spectrophotometer (Synergy HT, Bio-
Tek Instruments, Inc., USA) after incubating the mixture
at 60°C for 5min. Gallic acid (from Sigma Aldrich, St. Louis,
MO, USA) was used as a standard to achieve the calibration
curve (2,500-100mg/l, R2 = 0:996), and the results were
expressed in milligram gallic acid equivalent (GAE) per
gram of propolis or honey (mg GAE/g).
2.3.2. Total Flavonoid Content (TFC). Total flavonoids were
determined according to the procedure described by Kong
et al. [24]. Briefly, 100μl of honey or propolis extracts was
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mixed with sodium nitrite (5%) and 150μl of aluminum
chloride (AlCl3) (10%). After 5min, 200μl of sodium
hydroxide (NaOH) (1%) was added after a 1 h incubation
period in the dark. The intensity of the produced color was
measured at 510nm by a UV/Vis spectrophotometer
(Synergy HT, BioTek Instruments, Inc., USA). A calibration
curve (500-0mg/l, R2 = 0:998) was prepared using quercetin
(from Sigma Aldrich, St. Louis, MO, USA), and the flavo-
noid content was expressed as milligrams of the quercetin
equivalent per gram of the propolis or honey (mg QE/g).
2.3.3. Identification and Quantification of Polyphenol
Compounds by Ultraperformance Liquid Chromatography-
Diode Array Detector (UPLC-DAD). The aqueous solution
of honey and ethanolic extract of propolis were analyzed
using a Shimadzu Nexera X2 UPLC chromatograph
equipped with Diode Array Detector (DAD) (Shimadzu,
SPD-M20A, Kyoto, Japan) following the method described
and validated by Ferreira-Santos et al. [23]. Separation was
performed on a reversed-phase Equity UPLC BEH C18 col-
umn (2:1mm × 100mm, 1.7μm particle size; from Waters)
and a precolumn of the same material at 40°C. The flow rate
was 0.4ml/min. HPLC grade solvents water/formic acid
0.1% (A) and acetonitrile (B) were used. The elution gradi-
ent for solvent B was as follows: from 0.0 to 5.5min eluent
B at 5%, from 5.5 to 17min linearly increasing from 5 to
60%, and from 17.0 to 18.5min linearly increasing from 60
to 100%; the column was equilibrated at 5% from 18.5 to
30.0min. Phenolic compounds were identified by comparing
their UV spectra and retention times with that of corre-
sponding standards (vanillic acid (≥97.0% of purity), o-
coumaric acid (≥97.0%), ferulic acid (≥99.0%), ellagic acid
(≥95.0%), naringin (≥95.0%), hesperidin (≥97.0%), apigenin
(≥99.0%), cinnamic acid (≥99.0%), resveratrol (≥99.0%),
rosmarinic acid (≥98.0%), rutin (≥94.0%), chlorogenic acid
(≥95.0%), quercetin (≥95.0%), kaempferol (≥99.0%), and
gallic acid (≥99.0%) are obtained from Sigma Aldrich, St.
Louis, MO, USA). Quantification was carried out using cal-
ibration curves for each pure compound analyzed using con-
centrations between 250 and 2.5mg/l. In all cases, the
coefficient of linear correlation was R2 > 0:99. Compounds
were quantified and identified at different wavelengths
(209–370nm). The values of individual phenolic com-
pounds were expressed in milligrams per liter of samples
(mg/l). All analyses were made in triplicate.
2.4. Evaluation of In Vitro Antioxidant Activity
2.4.1. Free Radical Scavenging Activity (DPPH Assay). Two
hundred and seventy microliters of 2,2-diphenyl-1-picryl-
hydrazyl-hydrate (DPPH) solution (150μM, prepared in
methanol with an absorbance of 0:700 ± 0:01 at 515nm)
was added to 30μl of different dilutions of each sample
[23]. Then, the mixture reactions were incubated in the dark
for 1 h at room temperature. The absorbance was measured
at 515nm, and the antiradical activity (% inhibition) was
calculated using Equation (1). DPPH inhibition concentra-
tion at 50% (IC50) is determined using different dilutions
of each sample, considering that the percent inhibition had
to be between 20% and 80%, and the results were expressed
in milligrams of extract per milliliter (mg/ml). Ethanol 70%
and distilled water were used as control solutions instead of
the sample.
%inhibition = Abs control −Abs sampleAbs control × 100: ð1Þ
2.4.2. Radical Cation Decolorization (ABTS Assay). The
ABTS assay of honey and propolis extracts was determined
as follows: 200μl of 2,2′-azino-bis (3-ethylbenzothiazoline-
6-sulfonic acid) diammonium salt (ABTS) radical cation
solution (7mM of 2,2′-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) diammonium salt dissolved in ultrapure
water containing 2.45mM of potassium persulfate) was
mixed with 10μl of different dilutions of each extract. The
resulting solutions were incubated in the dark for 30min at
room temperature, and the intensity of produced color was
measured immediately at 734nm by a UV/Vis spectropho-
tometer (Synergy HT, BioTek Instruments, Inc., USA). The
ABTS radical cation inhibition percent was determined
using Equation (1) [23]. The IC50 results were expressed in
milligrams per milliliter.
2.4.3. Ferric Reducing Antioxidant Power (FRAP Assay). Two
hundred ninety microliters of FRAP reagent (10mM of
2,4,6-tri(2-pyridyl)-s-triazine solution (made in 40mM
HCl) mixed with 20mM of ferric chloride (FeCl3) and
0.3M acetate buffer (pH3.6) in a proportion of 1 : 1 : 10
(v/v/v)) was mixed with a 10μl aliquot of honey and propo-
lis extract, and the absorbance was determined at 593nm by
a UV/Vis spectrophotometer (Synergy HT, BioTek Instru-
ments, Inc., USA) after the incubation of the reaction mix-
ture in the dark at 37°C for 15min [23]. The aqueous
solution of ferrous sulfate FeSO4.7H2O (1000–100μM) was
used for standard curve preparation (R2 = 0:993). The FRAP
values are expressed as millimoles of ferrous equivalent per
gram of samples (mmol Fe2+/g).
2.5. Experimental Animal’s Protocol. Forty-two male Wistar
rats weighing 165:42 ± 5:8 g, obtained from the Animal
Housing Breeding Center, Department of Biology, Faculty
of Sciences Dhar El Mahraz, University Sidi Mohamed Ben
Abdallah, Fez, Morocco, were used for these experiments.
Rats were kept in a ventilated room and lived in standard
environmental conditions (22 ± 3°C, 55 ± 5% humidity, and
12 h light/dark cycles). The present work was designed
under ethical approval number (USMBA-SNAMOPEQ
2017-03), certified by Sidi Mohamed Ben Abdellah Univer-
sity, Fez, under the responsibility of the Animal Facility
and the Laboratory of Natural Substances, Pharmacology,
Environment, Modeling, Health and Quality of Life. The
manipulation of animals respected the EU Directive
2010/63/EU for animal experiments to avoid and minimize
animal suffering and the number of experimented animals.
Rats were randomly divided into 7 experimental groups
of 6 rats.
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Group DW (control group): received daily by gavage dis-
tilled water and injected with normal saline solution (1ml/kg
BW/day, i.p.).
Group PR (propolis group): received daily by gavage
propolis extract (100mg/kg BW) and injected with normal
saline solution (1ml/kg BW/day, i.p.).
Group H (honey group): received daily by gavage honey
(2 g/kg BW) and injected with saline solution (1ml/kg
BW/day, i.p.)
Group Gent (gentamicin group): received daily by gavage
distilled water and injected with GENT prepared in saline
solution (120mg/kg BW/day, i.p.)
Group Gent+PR (gentamicin/propolis group): received
daily by gavage propolis extract (100mg/kg BW) and
injected with GENT (120mg/kg BW/day, i.p.)
Group Gent+H (gentamicin/honey group): received daily
by gavage honey (2 g/kg BW) and injected with GENT
(120mg/kg BW/day, i.p.)
Group Gent+Pr+H (gentamicin/propolis/honey group):
received daily by gavage 100mg/kg BW of propolis extract
+2 g/kg BW of honey and injected with GENT (120mg/kg
BW/day, i.p.)
Rats of all groups received a normal chow diet (carbohy-
drate (48%), protein (21%), fat (3%), fiber (5%), calcium
(0.8%), phosphorus (0.4%), moisture (13%), and ash (8%))
twice a day.
The study lasted for 10 days. At the end of the experi-
ment, rats underwent fasting for 12 hours after their last
feeding; then, urine samples were collected using specific
metabolic cages, and blood samples were taken into tubes
from each rat by retroorbital bleeding under ether anesthe-
sia, and then, plasma was separated by centrifugation
(2000 g) during 10min.
The treatment duration was chosen according to [25].
Honey and propolis extract doses were selected based on
the studies of El-Haskoury et al. and El Menyiy et al.
[26, 27].
Honey and propolis were prepared every single day one
hour before their administration at a concentration of 2 g
of honey for 10ml and 100mg of dry propolis extract for
10ml. The combination of both samples was performed by
mixing 2 g of honey and 100mg of propolis dry extract in
10ml of distilled water. The combined mixture is vortexed
throughout the gavage period.
2.6. Biochemical Analysis. After 10 days of treatment, urine
and blood samples (plasma) were collected for the analyses
of different kidneys and liver biomarkers: urea (kit number
7D75-30, urease/NADH method), uric acid (kit number
7D76-20, Uricase/POD method), creatinine (kit number
7D64-20, picric acid/NaOH method), albumin (kit num-
ber7D53-20, bromocresol Green method), total protein
(kit number 7D73-20, biuret method), aspartate amino-
transferases (AST) (kit number 7D81-20, aspartate/NADH
method), alanine aminotransferases (ALT) (kit number
7D56-20, alanine/NADH method), alkaline phosphatase
(ALP) (kit numbers 7D55-20 and 7D55-20, colorimetric
method), and lactate dehydrogenase (LDH) (kit number
7D69-20, lactate/NAD method). C-reactive protein (CRP)
was estimated using kit numbers 6k26-30 and 6K26-41,
immunoturbidimetry method (Architect c8000i biochemis-
try analyzer) [28].
2.7. Liver and Kidney Antioxidant Enzyme Activities. Cata-
lase (CAT) activity was calculated according to the method
of [29]. A decrease in absorbance due to H2O2 degradation
was monitored spectrophotometrically at 240nm for 1min,
and the activity was expressed as μmol H2O2/min/mg pro-
tein. Glutathione peroxidase (GPx) activity was estimated
according to the method of [30]. The activity was expressed
as moles of GSH oxidized/min/mg protein.
2.8. Reduced Glutathione (GSH). GSH levels were measured
following the protocol described by Ellman [31]. Briefly, 3ml
of sulfosalicylic acid (4%) was added to 500ml of homoge-
nate liver and kidney tissues. The mixture was centrifuged
at 2,500 × g for 15min, and then prepared Ellman’s reagent
was added to 500ml of supernatant. The absorbance was
measured at 412nm after 10min. Total GSH content was
expressed as micrograms per milligram of protein.
2.9. Lipid Peroxidation (TBARS). The formation of products
of lipid peroxidation was quantified in liver and kidney
tissues using the thiobarbituric acid-reactive substances
(TBARS) method, as reported previously by Kassan et al.
[32], and absorbance was measured at 532nm. Results
were expressed as malondialdehyde (MDA) concentration
(nmol/g tissue).
2.10. Statistical Analysis. All data are presented as mean ±
SD ðstandard deviationÞ. Statistical comparisons between
the groups were performed with a one-way analysis of vari-
ance (ANOVA) followed by the Tukey test. Chi-square was
used to compare the difference in the proportion of the effect
of gentamicin, honey, propolis, or both of them on oxidative
parameters between kidney and liver. The GraphPad Prism®
software (version 5.0; GraphPad Software, Inc., San Diego,
USA) was used, and p < 0:05 was considered significant.
3. Results
3.1. Phytochemical Analysis and In Vitro Antioxidant
Activities of Honey and Propolis Extracts. As shown in
Table 1, propolis presented potent antioxidant activity. More
precisely, propolis extract contains 76:00 ± 2:15mg GAE/g
of total polyphenol content and 42:22 ± 0:96mg QE/g of
total flavonoid content. However, total polyphenol and
flavonoid contents in honey are 2:08 ± 0:04mg QE/g and
0:74 ± 0:01mg QE/g, respectively. The mixture of honey
and propolis showed 73:98 ± 4:27mg GAE/g of total poly-
phenols and 44:01 ± 0:13mg QE/g of flavonoids. Regarding
the IC50 of DPPH assay, propolis, honey, and their mixture
showed values of 0:15 ± 0:01mg/ml, 9:78 ± 0:95mg/ml, and
0:13 ± 0:02mg/ml, respectively. For ABTS antioxidant test,
the IC50 values are 0:08 ± 0:02mg/ml for propolis, 4:91 ±
0:12mg/ml for honey, and 0:41 ± 0:05mg/ml for honey
+propolis mixture, while the values of FRAP test were 2:15
± 0:04mmol Fe2+/g for propolis, 0:025 ± 0:00mmol Fe2+/g
for honey, and 2:27 ± 0:09mmol Fe2+/g for their mixture.
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3.2. Phenolic Compound Quantification from Honey and
Propolis Extracts. UHPLC-DAD analysis revealed the
presence of several phenolic compounds belonging to the
following groups: phenolic acids, flavonoids, flavanols,
flavanones, and stilbenes. As shown in Table 2, thirteen
phenolic compounds were quantified in propolis extract
and six were determined in honey solution. Rosmarinic acid
(470:35 ± 52:0mg/l), hesperidin (417:18 ± 50:0mg/l), and
resveratrol (116:89 ± 12:7mg/l) were the most abundant
phenolic compounds detected in hydroethanolic propolis
extract. Other detected components in propolis extract are
vanillic acid, o-coumaric acid, ferulic acid, ellagic acid, narin-
gin, apigenin, rutin, chlorogenic acid, quercetin, kaempferol,
and gallic acid. However, gallic acid (30:06 ± 0:23mg/l) was
the predominant compound found in honey followed by
ferulic acid (8:35 ± 0:01mg/l), chlorogenic acid (7:06 ± 0:11
mg/l), ellagic acid (5:09 ± 0:02mg/l), cinnamic acid (4:25 ±
0:01mg/l), and finally vanillic acid (2:90 ± 0:01mg/l).
3.3. Effect of Honey and Propolis Extracts on Renal
Biochemical Changes. The data in Figure 1 indicates that gen-
tamicin administration (120mg/Kg/BW) for 10 consecutive
days increased plasmatic levels of urea, uric acid, creatinine,
and CRP as well as decreased plasma albumin and total pro-
tein levels as compared to the control group (DW). The
cotreatment with propolis extract alone (100mg/Kg/BW) or
honey alone (2g/Kg/BW) or both (propolis+honey) signifi-
cantly prevented the increase of plasma urea, uric acid, creat-
inine, and CRP levels and increased plasma albumin and
total protein levels in comparison with group Gent. In addi-
tion, GENT injection induced a significant elevation in uri-
nary uric acid and total protein levels, while showed a
decrease in urea and urinary creatinine compared to the con-
trol group (DW). However, its coadministration with propo-
lis, honey, or their combination attenuated the deleterious
effects of GENT showed a significant decrease in urinary uric
acid and total protein levels accompanied by a higher level of
urinary urea and creatinine comparatively to the Gent group
(Figure 2). Propolis and honey showed no (negative) effects
on the kidney of normal rats.
3.4. Effect of Honey and Propolis Extracts on Liver
Biochemical Changes. Regarding hepatic function, GENT
treatment (group Gent) induced a significant increase in
enzymatic levels of AST, ALT, and ALP as compared to
the normal group (DW), while no significant change was
observed in plasma levels of LDH between studied groups
(Figure 3), whereas the cotreatment with propolis (Gent
+PR), honey (Gent+H), or their combination (Gent+PR
+H) showed a preventive effect in the increase of plasmatic
AST, ALT, and ALP levels promoted by GENT administra-
tion. Propolis and honey did not show negative effects on
liver normal rats.
3.5. Effect on Kidney Oxidative Stress. GENT administration
induced marker disorganization of oxidant status and pro-
teins in the kidney tissue, as characterized by a significant
reduction in CAT, GSH, GPx, and proteins with a concom-
itant elevation in MDA concentration compared to the DW
group (Table 3). However, the coadministration of propolis
alone, honey alone, or their association significantly lowered
the MDA levels and prevented the decrease of CAT, GSH,
and GPx, activities, and protein levels as compared to the
GENT group. These results demonstrated that propolis
and honey administrations especially their combination
improve the kidney state and exhibit a significant nephro-
protective effect by restoring the antioxidant capacity and
attenuating the oxidative stress in the kidney.
3.6. Effect on Liver Oxidative Stress. Regarding the liver tis-
sue, GENT treatment (group Gent) caused a remarkable
reduction in CAT, GSH, and GPx activities (p < 0:01) and
induced a decrease in protein content (p < 0:05) associated
with a high elevation in MDA (Table 4) in comparison with
the nontreated group (group DW), while the cotreatment
with propolis alone, honey alone, or their combination sig-
nificantly prevented the increase of MDA levels and pro-
motes beneficial effects on antioxidant enzyme activities, as
well in protein levels as compared to the GENT group.
3.7. Comparison between Kidney and Liver Oxidative Stress.
Regarding the effect of interventions on the kidney and liver
tissues, GENT caused a remarkable decrease in the CAT
(40.31 vs. 24.67%, p = 0:001), GSH (57.80 vs. 54.52%, p =
0:005), and a significant increase in the MDA (80.27 vs.
38.27%, p = 0:001) levels of the kidney in comparison with
the liver tissue. Also, GENT administration induced a signif-
icant decrease in liver protein compared to the kidney (39.44
vs. 28.58%, p = 0:002). The coadministration of propolis
(GENT+PR) significantly increased CAT, GSH, and GPx
activities (52.10 vs. 27.15%, p = 0:001; 111.87 vs. 80.78%, p
= 0:001; and 46.46 vs. 36.18%, p = 0:002, respectively) and
moderately decreased MDA levels (26.61 vs. 18.87%, p =
0:009) in the kidney as compared to the liver tissue. Like-
wise, the coadministration of propolis remarkably increased
the protein level in the kidney tissue liver (53.27 vs. 37.57%,
p = 0:001). The cotreatment with honey (Gent+H) showed a
significant elevation in the kidney CAT (32.36 vs. 23.58%,
Table 1: Phytochemical constituents and antioxidant activities of honey and propolis extracts.
Samples Polyphenols (mg GAE/g) Flavonoids (mg QE/g) DPPH IC50 (mg/ml) ABTS IC50 (mg/ml) FRAP (mmol Fe2+/g)
Honey 2:08 ± 0:04 0:74 ± 0:01 9:78 ± 0:95 4:91 ± 0:12 0:025 ± 0:00
Propolis 76:00 ± 2:15 42:22 ± 0:96 0:15 ± 0:01 0:08 ± 0:02 2:15 ± 0:04
Honey+propolis 73:98 ± 4:27 44:01 ± 0:13 0:13 ± 0:02 0:41 ± 0:05 2:27 ± 0:09
DPPH: 2,2-diphenyl-1-picryl-hydrazyl-hydrate; ABTS: 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt; FRAP: ferric reducing
antioxidant power.
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p = 0:001), GSH (99.00 vs. 87.31%, p = 0:003), GPx (34.65 vs.
21.56%, p = 0:003), and protein (72.08 vs. 50.29%, p = 0:001)
as well as expressed a significant decrease in MDA (23.82 vs.
18.00%, p = 0:031) in comparison to their levels in the liver
tissue. The combined cotreatment (Gent+PR+H) increased
significantly the levels of CAT (58.29 vs. 29.32%, p = 0:001)
and GSH (122.54 vs. 97.80%, p = 0:001) in the kidney as
compared to the liver tissue as well as increased the lower
level of proteins (57.09 vs. 41.92%, p = 0:001) and GPx activ-
ity in the liver tissue than in the kidney tissue (50.18 vs.
35.79%, p = 0:001) (Table 5).
3.8. The Effect of Propolis, Honey, or Their Combination on
the Gentamicin-Induced Body and Organ Weight Changes.
As shown in Table 6, gentamicin injection induced a marked
reduction in body weight gain accompanied by a significant
increase in the relative kidneys and liver weights. However,
the treatment with propolis (Gent+Pr), honey (Gent+H),
or their mixture (Gent+Pr+H) prevented the body-weight
loss and improved the relative organs’ weights.
4. Discussion
4.1. Phytochemical Constituents and Antioxidant Activities of
Honey and Propolis Extracts. The identification and quanti-
fication of bioactive components of natural products are cru-
cial tests to better understand the pharmacological effects
and their effectiveness. Flavonoids and other phenolic com-
pounds are powerful antioxidant molecules with a stronger
ability to fight free radicals that induce oxidative stress
[33]. DPPH, ABTS, and FRAP are the most commonly used
tests to evaluate the antioxidant activities of various biologi-
cal matrices, evaluating different mechanisms of action. The
present study illustrates that propolis has a more affluent
profile of antioxidant phenolic compounds when compared
to honey alone or mixed with propolis extract. Polyphenol
content in propolis extract was 76:00 ± 2:15mg GAE/g,
and the value obtained was higher than the data reported
by Touzani et al. [34] for propolis sample harvested from
the same locality where our evaluated sample was collected
(Sefrou). The flavonoid content (42:22 ± 0:96mg QE/g)
was higher than those obtained by Miguel et al. [35] for
Moroccan propolis, where the values ranged from 0.2 to
34.3mg QE/g. The amount of antioxidant (flavonoids and
nonflavonoids) compounds in propolis depends strongly
on the botanical origin of resin and pedoclimatic character-
istics of the collecting region, which explain the wide fluctu-
ation between the evaluated sample and other propolis
samples from different localities [18, 36]. Regarding antiox-
idant activity, the propolis extract concentration required
to inhibit 50% of DPPH was 0:15 ± 0:01mg/ml. Data are
in line with those reported by Miguel et al. [35] who studied
fourteen propolis samples harvested from different ecoregio-
nal origins in Morocco, with IC50 values oscillated between
0.025mg/ml and 1.813mg/ml. ABTS and FRAP activities
were 0:08 ± 0:02mg/ml and 2:15 ± 0:04mmol Fe2+/g,
respectively. The FRAP value was higher than those signaled
by Svečnjak et al. [37] for Adriatic Sea islands propolis,
ranging between 0.1 and 0.8mmol Fe2+/g.
Concerning honey, the polyphenol content was 2:08 ±
0:04mg GAE/g, which was higher than those reported by
Petretto et al. [38] for teen Moroccan monofloral honey.
Regarding antioxidant activities, the concentration of honey
necessary to inhibit 50% of DPPH radical was 13:53 ± 1:3
mg/ml, and this value was similar to the results of Laaroussi
and coworkers [11] reported on eight Moroccan honey sam-
ples, varied from 13.54 to 45.34mg/ml and higher than those
signaled for the Malaysian honey ranging from 6.12 to
11.56mg/ml [39]. There is a strong correlation between the
pollen profile of different honey samples and their amount
in phenolic and flavonoid compounds [11]. In addition to
the floral origin, the wide variation seen between the antiox-
idant compounds of examined sample and those reported by
other investigations is attributed to many other factors
including harvest season and geographical and environmen-
tal characteristics of the areas where it is produced [40].
ABTS and FRAP activities were 4:91 ± 0:12mg/ml and
0:025 ± 0:00mmol Fe2+/g, respectively. The ABTS and
FRAP values of analyzed honey were found to be lower than
those reported by Kıvrak and Kıvrak [41] for Turkish honey,
where ABTS values are oscillating from 8.22 to 41.20mg/ml
and by Mahmoodi-Khaledi et al. [42] where FRAP values are
ranging between 0.027 and 0.182mmol Fe2+/g. It is well doc-
umented that in vitro interactions between phytobioactive
components induce changes in overall antioxidant capacities
[43]. The mixture of honey and propolis extract showed a
higher amount of phenolics and flavonoids and displayed
strong DPPH radical scavenging capacity, ABTS scavenging
capacity, and high reducing power antioxidant activity
(FRAP) as compared to honey alone and revealed higher
antioxidant activities (DPPH and FRAP) as compared to
Table 2: Phenolic compound identification and quantification of
honey and propolis extracts.
Compounds Propolis Honey
Vanillic acid 8:61 ± 0:30 2:90 ± 0:01
o-Coumaric acid 11:44 ± 4:63 n.d.
Ferulic acid 18:84 ± 0:21 8:35 ± 0:01
Ellagic acid 28:55 ± 1:99 5:09 ± 0:02
Naringin 35:78 ± 4:10 n.d.
Hesperidin 417:18 ± 50:0 n.d.
Apigenin 38:39 ± 2:60 n.d.
Cinnamic acid n.d. 4:25 ± 0:01
Resveratrol 116:89 ± 12:7 n.d.
Rosmarinic acid 470:35 ± 52:00 n.d.
Rutin 12:40 ± 0:42 n.d.
Chlorogenic acid 16:11 ± 0:12 7:06 ± 0:11
Quercetin 12:02 ± 0:13 n.d.
Kaempferol 21:90 ± 1:60 n.d.
Gallic acid n.d. 30:06 ± 0:23
Total 1208.5 57.7
Values of phenolic compounds are expressed as concentration (mg/l)
mean ± SD of 3 experiments. n.d.: not detected.
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propolis extract alone (Table 1). Substantially, the examined
extracts (alone or in the mixture) showed powerful antioxi-
dant capacities, which are possibly related to their individual
antioxidant components mainly flavonoids, phenolic acids,
and terpenoids as well as to the possible interaction between






















































































































































































































Figure 1: Effect of propolis, honey, or their combination on gentamicin-induced changes in (a) plasmatic urea, (b) uric acid, (c) creatinine,
(d) albumin, (e) total protein, and (f) CRP in Wistar rats. The results were presented as mean ± SD of 6 rats; DW: distilled water; Pr:
propolis; H: honey; Gent: gentamicin. aComparison between the DW group and all groups; bcomparison between the Gent group and
gentamicin cotreated groups.










































































8 Oxidative Medicine and Cellular Longevity
effect of gallic acid, caffeic acid, quercetin, catechin alone, or
in combination with resveratrol using three different antiox-
idant assays (DPPH, FRAP, and Briggs–Rauscher reaction)
[44]. The obtained results showed better antioxidant capac-
ities of evaluated compounds when tested in the mixture
form as compared with the activities displayed when testing
individual compounds, which proves the possible interac-
tion between these bioactive components leading to syner-
gistic antioxidant effects.
4.2. Effect of Interventions on Renal Function
4.2.1. Effect on Kidney Biochemical Changes. Nowadays,
infectious diseases are a challenging public health problem
worldwide, and face to bacterial resistance and antibiotics
overuse including GENT may prompt side effects such as
hepatorenal toxicities [45].
The present data showed that GENT (120mg/kg BW)
caused kidney dysfunction demonstrated by a significant ele-
vation in blood levels of urea, uric acid, and creatinine and a
remarkable decrease in plasmatic albumin and total protein
levels. In addition, GENT administration increased urinary
uric acid and protein levels and decreased urea and creati-
nuria levels, which are classified as a major sign of renal
tubular necrosis and kidney damage [46]. These results are
similar to the data reported by Marinho et al. [47]. A study
published by Al Za’abi et al. [48] showed that GENT reduces










































































Figure 2: Effect of propolis, honey, or their association on gentamicin-induced changes in (a) urinary urea, (b) uric acid, (c) creatinine, and
(d) total protein in Wistar rats. The results were presented as mean ± SD of 6 rats; DW: distilled water; Pr: propolis; H: honey; Gent:
gentamicin. aComparison between the DW group and all groups; bcomparison between the Gent group and gentamicin cotreated groups;
dcomparison between the Gent+H group and the Gent+Pr+H group. ∗p < 0:05, ∗∗p < 0:01, and ∗∗∗p < 0:001.







































































10 Oxidative Medicine and Cellular Longevity
tubular cells by inhibiting its phosphorylation process,
which leads to low membrane integrity and thus the sensitiv-
ity to the overproduction of free radicals [49]. The animals
submitted to GENT injection and cotreated with propolis
alone (Gent+PR), honey (Gent+H), or their association
(Gent+PR+H) restored all investigated plasmatic and uri-
nary biomarkers. Similar data have been reported by Aldah-
mash and coworkers [50]. The pharmacological effects of
functional organic products are most often linked to their
phenolic compound composition and their ability to coun-
teract free radicals [51]. In vitro investigations showed that
honey and propolis extracts contain several bioactive mole-
cules including rosmarinic acid, resveratrol, hesperidin,
and gallic acid. Tavafi and coworkers have reported that ros-
marinic acid exerts its renoprotective action by inhibiting
lipid peroxidation and upregulating renal GSH, GPx, and
CAT activities as well as by decreasing renal MDA levels
[52]. Moreover, rosmarinic acid was found to protect kidney
damage caused by cisplatin through the downregulation of
tumor suppressor p53 and p-p53 and reduction of cleaved
caspase-3, signifying the inhibition of tubular apoptosis
[53]. As a part of its nephroprotective action, resveratrol
has been revealed to inhibit the expression of transforming
growth factor-beta (TGF-β), transforming growth factor-
beta receptor1 (TGF-βR1), and Smad3 that play a key role































































Figure 3: Effect of propolis, honey, or their combination on gentamicin-induced changes in (a) aspartate aminotransferases (AST), (b)
alanine aminotransferases (ALT), (c) lactate dehydrogenase (LDH), and (d) alkaline phosphatase (ALP) in Wistar rats. The results were
presented as mean ± SD of 6 rats; DW: distilled water; Pr: propolis; H: honey; Gent: gentamicin. aComparison between the DW group
and all groups; bcomparison between the Gent group and gentamicin cotreated groups; ccomparison between the Gent+Pr group and the
Gent+Pr+H group; dcomparison between the Gent+H group and the Gent+Pr+H group. ∗p < 0:05, ∗∗p < 0:01, and ∗∗∗p < 0:001.
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4.2.2. Effect on Kidney Oxidative Parameters. It has been
proven that overproduced ROS induces oxidative stress
and organ damage. In this study, GENT administration
deteriorates the renal antioxidant defense system and
increases oxidative biomarkers. Rats injected with 120mg/kg
of GENT without cotreatment for 10 consecutive days
expressed low CAT, GSH, and GPx activities and high levels
of renal MDA. Results obtained from the current study are
consistent with the findings of Edeogu et al. [55] in which
GENT administration (100mg/kg BW) markedly increased
renal MDA levels and significantly depressed renal activities
of GSH, SOD, CAT, and GPx levels in kidney tissues.
It was suggested that GENT may trigger the release of
renal mitochondrial iron to form a Fe–GENT complex
which promotes the overproduction of ROS and other free
radicals such as H2O2 [56]. The generated H2O2 enhances
the production of superoxide anions (O2
•-) in the renal
mitochondrial cortex [57]. In the presence of redox metal
ions, hydrogen peroxide (H2O2) and superoxide ion (O2
•-)
generate hydroxyl radical (HO•) which is considered as
one of the most damaging ROS [58]. Moreover, [59] found
that GENT enhances the overexpression of proinflammatory
cytokines such as interleukin-6 (IL-6) and tumor necrosis
factor-α (TNF-α) which largely contributes to tissue injury
and leads to the development of various complications
including nephrotoxicity. Likewise, GENT overuse leads to
mitochondrial dysfunction and promotes the excessive gen-
eration of free radicals, which are considered as potent oxi-
dizing agents that elicit lipid proteins and DNA oxidative
damage via the upregulation of NADPH oxidase 4 (NOX4)
and the suppression of adenine nucleotide translocase 2
(ANT2) [60–63]. Accordingly, the chronic accumulation of
oxidative DNA injuries may enhance mutagenesis and
human pathogenesis [64]. Interestingly, the coadministra-
tion of honey, propolis, or their association had significantly
increased the activities of antioxidant enzymes and prevents
the increased level of MDA in the kidney, which confirms
their nephroprotective ability. These results were in agree-
ment with the findings of [26], in which Moroccan carob
honey increased CAT, GSH, SOD, and GPx activities and
Table 3: Effect of propolis, honey, or their combination on gentamicin-induced changes in kidney antioxidant enzymes, proteins, and MDA
concentrations.
Experimental groups











DW 12:08 ± 0:31 95:03 ± 5:32 15:72 ± 0:28 4:16 ± 0:07 62:46 ± 3:24
Pr 12:19 ± 0:23 96:76 ± 4:84 15:12 ± 0:37 4:18 ± 0:19 62:86 ± 8:65
H 12:11 ± 0:41 97:89 ± 5:11 15:17 ± 0:31 4:82 ± 0:13 59:97 ± 6:37
Gent 7:21 ± 0:41a∗∗∗ 40:10 ± 2:55a∗∗∗ 9:67 ± 0:22a∗∗∗ 2:96 ± 0:11a∗∗∗ 112:54 ± 9:10a∗∗∗
Gent+Pr 10:96 ± 0:84b∗∗∗ 84:69 ± 4:09a∗b∗∗∗ 14:17 ± 0:18a∗b∗∗∗ 4:09 ± 0:09b∗∗∗ 82:59 ± 11:02b∗
Gent+H 9:54 ± 0:69a∗∗∗b∗∗ 79:80 ± 4:97a∗b∗∗ 13:02 ± 0:19a∗∗b∗∗∗ 5:12 ± 0:018a∗∗∗b∗∗∗ 85:77 ± 10:96b∗
Gent+Pr+H 11:41 ± 0:39b∗∗∗d∗∗ 89:24 ± 7:45b∗∗∗d∗ 13:14 ± 0:30a∗b∗∗∗c∗ 4:22 ± 0:24b∗∗∗d∗∗∗ 79:71 ± 8:15b∗∗
CAT: catalase; GSH: glutathione; GPx: glutathione peroxidase; MDA: malondialdehyde. The results were presented as mean ± SD of 6 rats; DW: distilled
water; Pr: propolis; H: honey; Gent: gentamicin. aComparison between the DW group and all groups; bcomparison between the Gent group and
gentamicin cotreated groups; ccomparison between the Gent+Pr group and the Gent+Pr+H group; dcomparison between the Gent+H group and the Gent
+Pr+H group. ∗p < 0:05, ∗∗p < 0:01, and ∗∗∗p < 0:001.
Table 4: Effect of propolis, honey, or their combination on gentamicin-induced changes in enzymatic antioxidants hepatic levels, proteins,
and MDA levels.
Experimental groups











DW 15:74 ± 1:02 98:32 ± 3:42 8:09 ± 0:83 6:63 ± 0:19 45:20 ± 2:12
Pr 16:00 ± 1:30 99:91 ± 4:07 8:90 ± 0:58 6:67 ± 0:75 44:12 ± 0:85
H 15:42 ± 1:02 96:30 ± 2:64 9:12 ± 0:47 6:52 ± 0:37 45:81 ± 1:26
Gent 11:85 ± 1:08a∗∗ 44:71 ± 2:91a∗∗ 5:40 ± 0:89a∗∗∗ 4:01 ± 0:58a∗ 62:42 ± 1:34a∗∗∗
Gent+Pr 15:07 ± 0:87b∗ 80:83 ± 1:19b∗∗∗ 7:86 ± 0:81a∗∗b∗ 6:15 ± 0:72b∗ 50:64 ± 1:48b∗∗
Gent+H 14:65 ± 0:92b∗ 83:75 ± 2:78b∗∗∗ 7:11 ± 0:88a∗ 6:03 ± 0:73b∗ 51:23 ± 0:98b∗∗
Gent+Pr+H 15:33 ± 0:72b∗∗∗ 88:40 ± 1:39b∗∗∗d∗ 8:11 ± 0:55b∗ 6:31 ± 0:79b∗ 48:12 ± 1:08b∗∗∗c∗
CAT: catalase; GSH: glutathione; GPx: glutathione peroxidase; MDA: malondialdehyde. The results were presented as mean ± SD of 6 rats; DW: distilled
water; Pr: propolis; H: honey; Gent: gentamicin. aComparison between the DW group and all groups; bcomparison between the Gent group and
gentamicin cotreated groups; ccomparison between the Gent+Pr group and the Gent+Pr+H group; dcomparison between the Gent+H group and the Gent
+Pr+H group. ∗p < 0:05, ∗∗p < 0:01, and ∗∗∗p < 0:001.
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ascorbic acid as well decreased MDA levels in renal and liver
tissues of rats treated with carbon tetrachloride (CCL4). In
the same context, the results of Shi et al. showed that prop-
olis improves streptozotocin-induced renal dysfunction and
oxidative stress by inhibiting lipid peroxidation and amelio-
rating antioxidant system defenses [65]. Owing to its health-
promoting compounds, honey inhibits the production of
proinflammatory cytokines NOx, IL-6, TNF-α, MCP-1, IL-
12p70, IFN-γ, and IL-10 and attenuates nuclear factor-
kappa B (NF-κB) translocation to the nucleus [66]. Due to
their rich composition in bioactive molecules, honey and
propolis might have renoprotective action through one or
different signaling pathways (Figure 4). Indeed, gallic acid,
a hydroxybenzoic acid present at a high concentration in
honey, displays its nephroprotective effects via the modula-
tion of oxidative stress and inhibition of inflammatory
response [67]. Moreover, hesperidin, a flavonoid present in
bee products, prevents kidney damage by inhibiting the
cyclooxygenase-2/prostaglandin E2 (COX-2/PGE2) signal-
ing pathway [68].
Overall, the nephroprotective effect of investigated
honey and propolis extracts could be due to the interaction
between their bioactive components through diverse signal-
ing pathways (Figure 4).
4.3. Effect of Interventions on Liver Function
4.3.1. Effect on Liver Biochemical Changes. The current find-
ings showed that GENT-treated rats exhibited extreme liver
damage manifested by a remarkable increase in plasma
levels of ALT, AST, and ALP (Figure 3). These results were
similar to those reported by Hegazy et al. [69]. The high
plasmatic activity of the examined enzymes reflects hepatic
cell necrosis and liver structural changes, which leads to
their secretion into the bloodstream from the cytosol [70].
However, GENT animals cotreated with propolis, honey,
or their association expressed a significant decrease in plas-
matic AST, ALT, and ALP levels, which indicate that honey
and propolis extract especially their combination blocked
the enzyme leakage and prevented GENT-caused kidney
dysfunction. These results go on hand with the findings of
El-Haskoury et al. [26] who reported that honey exhibited
strong hepatoprotective action against CCL4-induced toxic-
ity. Likewise, propolis extract (150mg/kg BW) was found
able to prevent kidney injury and renal dysfunction induced
by aluminum chloride in rats [17].
4.3.2. Effect on Liver Oxidative Parameters. In addition to the
biochemical investigations, the assessment of liver oxidative
stress showed that GENT treatment decreased significantly
CAT, GSH, and GPx activities, as well as protein levels with
a concomitant increase in liver MDA level, a major sign that
the organ is functionally compromised, with an imbalance of
its redox state. It is well reported that liver tissue is rich in
polyunsaturated fatty acids (PUFAs), which are sensitive to
peroxidative damage [71]. Alterations in gene expression
profiles resulting from chronic exposure to xenobiotic
substances have a negative impact on human health [72].
A previous study showed that CCL4 treatment downregu-
lated the mRNA expression of SOD, GPx, and CAT, which
was reversed by Actiniopteris radiata active compounds in
a dose-dependent manner [73]. The suppressed activity of
these antioxidant enzymes may be due to the interruption
of their synthesis by the overproduced ROS and other free
radicals, which could be the same mechanism involved
following the GENT treatment. Additionally, it has been
Table 5: Comparison between kidney and liver oxidative/antioxidant status.
Parameter
Gent Gent+PR
Kidney Liver Kidney Liver
Effect %A Effect %A p Effect %B Effect %B p
CAT Decrease 40.31 Decrease 24.67a 0.001 Increase 52.10 Increase 27.15b 0.001
GSH Decrease 57.80 Decrease 54.52a 0.005 Increase 111.87 Increase 80.78b 0.001
GPx Decrease 38.43 Decrease 40.56a 0.006 Increase 46.46 Increase 36.18b 0.002
Proteins Decrease 28.58 Decrease 39.44a 0.002 Increase 37.53 Increase 53.27b 0.001
MDA Increase 80.27 Increase 38.27a 0.001 Decrease 26.61 Decrease 18.87b 0.009
Parameter
Gent+H Gent+PR+H
Kidney Liver Kidney Liver
Effect %C Effect %C p Effect %D Effect %D p
CAT Increase 32.36 Increase 23.58c 0.001 Increase 58.29 Increase 29.32d 0.001
GSH Increase 99.00 Increase 87.31c 0.003 Increase 122.54 Increase 97.80d 0.001
GPx Increase 34.65 Increase 31.56c 0.002 Increase 35.79 Increase 50.18d 0.001
Proteins Increase 72.08 Increase 50.29c 0.001 Increase 41.92 Increase 57.09d 0.001
MDA Decrease 23.82 Decrease 18.00 0.031 Decrease 29.21 Decrease 24.36 0.171
%A: percentage of changes from the control induced by GENT administration; %B: percentage of changes from the GENT caused by propolis administration:
%C: percentage of changes from the GENT caused by honey administration; %D: percentage of changes from the GENT caused by propolis+honey
administration. ap < 0:05: statistically significant as compared to the effect GENT on kidney oxidative parameters; bp < 0:05: statistically significant as
compared to the effect GENT+PR on kidney oxidative parameters; cp < 0:05: statistically significant as compared to the effect GENT+H on kidney
oxidative parameters; dp < 0:05: statistically significant as compared to the effect GENT+PR+H on kidney oxidative parameters.







































































































































































































































































































































































































































































































































































































































































14 Oxidative Medicine and Cellular Longevity
documented that total protein and globulin levels were cor-
related positively with SOD and GPx activities of rats treated
with curcumin against sodium salicylate-induced oxidative
liver and kidney damages [74].
However, rats receiving GENT and simultaneously
treated with honey, propolis, or their combination expressed
lower MDA levels and higher CAT, GSH, GPx activities and
protein contents. Similar data have been documented by
other researchers [75, 76]. In a human trial study, Diniz
et al. have reported that the administration of microencap-
sulated standardized Brazilian green propolis extract (375
and 750mg/day) during 7 days rose the endogenous enzy-
matic and nonenzymatic antioxidants and reduced the bio-
markers associated with the cellular membrane and DNA
damage in healthy young participants [77]. Similarly, Ebeid
and coworkers have demonstrated that propolis supplemen-
tation (400mg, 3 times daily) for 10 consecutive days before
and 10 days after the radiotherapy session had been able to
reduce significantly the DNA oxidative damage of breast
cancer patients [78]. This effect was expected since several
propolis components could promote the DNA repair pro-
cesses, which in turn scavenge the free radicals generated
by chemotherapeutic agents and counteract the impairment
caused by infrared radiations [79]. In vitro, similar results
were documented by Haza and Morales [80] in which poly-
floral honey improved the antioxidant defense system and
protected HepG2 cells against different food mutagen-
induced DNA oxidative damage.
The hepatoprotective action of these bioactive products
could be attributed to their antioxidant content which assists
in the preservation of membrane integrity. Honey and prop-
olis extracts contain a variety of natural antioxidants, such as
flavonoids, flavan-3-ols, hydroxybenzoic acids, hydroxycin-
namic acids, and stilbenes (Table 2), which make them func-
tional foods with a broad spectrum of pharmacological
activities. The antioxidative properties of phenolic compo-
nents are related to several mechanisms of action including,
singlet oxygen quenching, free radical scavenging, metal ion
chelation, and hydrogen donation [81]. Previous works doc-
umented that phenolic compounds possess several biological
activities and numerous beneficial health effects. The out-
come of Mahmoud and coworkers [82] showed that ferulic
acid prevents oxidative stress and exerts its hepatoprotec-
tive activity against methotrexate-induced hepatotoxicity
through the upregulation of nuclear factor erythroid 2-
related factor/heme oxygenase-1 (Nrf2/HO-1) signaling
pathway. Gallic and hydroxybenzoic acids present in our
studied samples prevent liver injury by modulating the
expression and phosphorylation of epidermal growth factor
receptor (EGFR) [83]. A previous study reports that kaemp-
ferol has been revealed to exert a potent hepatoprotective
effect by inhibiting cytochrome P-450 2E1 (CYP2E1) and
thus reducing ROS production [84]. In the same context,
chlorogenic acid, an active phenolic compound found in
bee products, has been already documented to have potent
antiradical action and high preventive ability on arsenic-
induced oxidative stress and apoptosis [85]. The food syn-
ergy notion, which assumes that different dietary constitu-
ents have additive or even synergistic effects on human
health, has been previously pointed out [21]. As found in
nature, bioactive compounds are usually present in mixture
form, which increases the possibility of interactions between
them. The combination of food extracts or their bioactive
compounds may enhance the in vitro antioxidant status
and promote the in vivo antioxidants/ROS ratio [86]. For
instance, a binary combination of α-tocopherol with kaemp-
ferol or myricetin showed a better preventive effect on free
radicals inducing oxidative stress and lipid peroxidation than
each component alone [87]. Likewise, rats fed a diet supple-
mented with a mixture of quercetin (30mg/kg/day) and
resveratrol (15mg/kg/day) synergistically reduced the fat
accumulation in the white adipose tissue and improve triac-
ylglycerol metabolism [88]. Moreover, Baranowska and
coworkers have reported that quercetin combined with nar-
ingenin improves synergistically cellular redox status and
reduces global DNA methylation [89].
Overall, the hepatoprotective action documented by our
examined samples could be related to molecular interactions
between their individual bioactive constituents through one
or several signaling pathways (Figure 4).
Figure 4: Proposal mechanism of action of honey and propolis against hepatorenal toxicity and oxidative stress induced by gentamicin.
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4.4. Effect of Interventions on Body and Organ Weight
Changes. The rats’ weights were measured at the beginning
and the end of the experiment. Gentamicin treatment
(120mg/kg BW/day, i.p.) exhibited a significant reduction
in body weight gain as compared to the normal untreated
rats (DW). The documented body weight loss was in agree-
ment with the findings of Sahu et al. [90]. This could be
attributed to the skeletal muscle protein and lipid break-
down in adipose tissue [91]. Hence, the coadministration
of propolis (Gent+Pr), honey (Gent+H), and especially their
combination (Gent+Pr+H) prevents markedly the final body
weight loss. Both the control, propolis, and honey groups
showed similar weights. The body weight change was
accompanied by the alteration of the liver and kidney
weights. The data (Table 6) showed that the daily adminis-
tration of propolis or honey to normal rats does not affect
the organs’ relative weight. The data illustrates that the intra-
peritoneal injections of gentamicin (120mg/kg BW/day, i.p.)
for 10 consecutive days lead to a significant increase of
organs’ relative weight in comparison with the normal
group, and this goes in hand with the findings of Laaroussi
et al. [92]. The relative organ weight increase might be
related to the inflammatory and oxidative stress effects of
gentamicin overuse. GENT-rats simultaneously cotreated
with honey alone, propolis alone, or both showed a signifi-
cant decrease in the liver and kidney relative weights, with
the best data displayed by the combined coadministration
(Gent+Pr+H). This is consistent with the result of Nassar
and coworkers, in which propolis, honey, and their mixture
prevent the liver, kidney, heart, and lung relative weight
decrease [93].
5. Conclusion
Phytochemical analysis of bee honey and propolis extracts
showed the presence of several natural antioxidants belong-
ing to different chemical groups: flavonoids, phenolic acids,
flavonols, and stilbenes. These may be responsible for the
documented efficacy of bee honey and propolis extracts in
protecting biochemical characteristics and enzymatic activi-
ties of kidneys and liver tissues from alterations induced by
gentamicin. Overall, daily intake of propolis and/or honey
could offer promising protective effects on hepatic and renal
functions, as well as maintaining the redox homeostasis.
Further investigations would be needed to evaluate and
understand the exact mechanism by which these extracts,
possibly phenolic compounds, improve gentamicin-cause
oxidative stress and hepatorenal injuries.
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